Article Text
Abstract
Objectives Reaching the Patient-Acceptable Symptom State (PASS) threshold for the Knee injury and Osteoarthritis Outcome Score (KOOS) has previously been reported to successfully identify individuals experiencing clinical success after anterior cruciate ligament reconstruction (ACLR). Thus, the objectives of this study were to examine and compare the percentages of patients meeting PASS thresholds for the different KOOS subscales 1 year postoperatively after primary ACLR compared with revision ACLR (rACLR) and multiply revised ACLR (mrACLR), and second, to examine the predictors for reaching PASS for KOOS Quality of Life (QoL) and Function in Sport and Recreation (Sport/Rec) after mrACLR.
Design Prospective observational registry study.
Setting The data used in this study was obtained from the Swedish National Ligament Registry and collected between 2005 and 2020.
Participants The study sample was divided into three different groups: (1) primary ACLR, (2) rACLR and (3) mrACLR. Data on patient demographic, injury and surgical characteristics were obtained as well as mean 1-year postoperative scores for KOOS subscales and the per cent of patients meeting PASS for each subscale. Additionally, the predictors of reaching PASS for KOOS Sport/Rec, and QoL subscales were evaluated in patients undergoing mrACLR.
Results Of the 22 928 patients included in the study, 1144 underwent rACLR and 36 underwent mrACLR. Across all KOOS subscales, the percentage of patients meeting PASS thresholds was statistically lower for rACLR compared with primary ACLR (KOOS Symptoms 22.5% vs 32.9%, KOOS Pain 84.9% vs 92.9%, KOOS Activities of Daily Living 23.5% vs 31.4%, KOOS Sport/Rec 26.3% vs 45.6%, KOOS QoL 26.9% vs 51.4%). Percentages of patients reaching PASS thresholds for all KOOS subscales were comparable between patients undergoing rACLR versus mrACLR. No predictive factors were found to be associated with reaching PASS for KOOS QoL and KOOS Sport/Rec 1 year postoperatively after mrACLR.
Conclusion Patients undergoing ACLR in the revision setting had lower rates of reaching acceptable symptom states for functional knee outcomes than those undergoing primary ACLR.
Level of evidence Prospective observational registry study, level of evidence II.
- Knee
- Musculoskeletal disorders
- Orthopaedic sports trauma
- Adult orthopaedics
- SPORTS MEDICINE
Data availability statement
Data are available upon reasonable request. The datasets obtained analysed during the current study are available from the corresponding author on reasonable request.
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
Strengths and limitations of this study
The large sample size allows assessment of outcomes following anterior cruciate ligament (ACL) reconstruction among different ages, sexes and ethnicities.
Considering the high coverage rate of ACL injuries in the registry, the study sample can be considered representative of the Swedish population.
The results of the study may not be generalisable to other countries where different injury mechanisms and treatment approaches may be more common.
Introduction
As the number of anterior cruciate ligament reconstructions (ACLR) increases, the incidence of revision ACLR (rACLR) continues to rise, with rates as high as 15%–25% after primary ACLR.1–3 Patient-reported knee function and rate of return to sport after rACLR is widely accepted as inferior to that following the primary procedure,4 5 yet, less data exists on the multiply revised ACLR (mrACLR) and how its outcomes compare to rACLR.
The Patient-Acceptable Symptom State (PASS) threshold is a single-item treatment-response criteria which requires that a patient consider all aspects of life to determine whether the state of his or her joint is satisfactory after an intervention.6 It was developed through an anchor method where one, ‘simple’ question on acceptable knee function is linked to a patient-reported outcome to establish cut-off values that determine the clinical relevance of a treatment’s effect.7 These values have been developed for several patient-reported outcomes following various surgical procedures, including ACLR.8 In fact, reaching the PASS threshold for Knee injury and Osteoarthritis Outcome Score (KOOS) has successfully identified individuals who have experienced clinical success after ACLR with high sensitivity.9 Vega et al defined clinical success in their study as ‘changes in preoperative scores on the KOOS Pain subscale and the KOOS Knee Related Quality of Life (QoL) subscale in excess of minimally important difference or final KOOS Pain or QoL subscale scores in excess of previously defined PASS thresholds’.9 A 2020 ACLR consensus group concluded that measurement of PASS is valuable in the assessment of outcomes after ACLR and should be a priority, as the question of whether a patient perceives an acceptable symptom state is important.10 Furthermore, it is agreed that PASS values provide a tool to assist clinicians in the interpretation of patient-reported outcomes,10 thus PASS values can assist clinical decision-making. Numerous studies are present in the literature reporting predictive factors and percentages of patients meeting PASS thresholds after primary ACLR for the different KOOS subscales.9 11–15 However, less data exists exploring the predictors and percentages of patients meeting PASS for the different KOOS subscales in the rACLR setting. Thus, this information would be particularly important for a better understanding of different subjective patient outcomes and counselling patients before their respective surgery about their future subjective Quality of Life (QoL) and knee function.
As such, the primary purpose of the study was to examine and compare the percentages of patients meeting PASS thresholds for the different KOOS subscales 1 year postoperatively after primary ACLR compared with rACLR and mrACLR. Secondarily, it sought to examine the injury-, patient- and surgery-related predictors for reaching PASS for KOOS QoL and Function in Sport and Recreation (Sport/Rec) after mrACLR as these subscales have previously been recognised as viable subscales for assessing knee function and QoL in patient undergoing ACLR.16 17
Methods
The Strengthening the Reporting of Observational Studies in Epidemiology guidelines were used to present this study.18
The data used in this study was obtained from the Swedish National Knee Ligament Registry (SNKLR), which covers information on patients who have undergone ACLR in Sweden. The registry boasts a coverage rate of over 90% and was created in January 2005. The data collected in the SNKLR includes information reported by both the patient and surgeon, such as demographical data, injury and surgical characteristics and patient-reported outcome measures. Surgeons report all demographical data, injury and surgery-related data, while patients complete questionnaires regarding their current knee function at 1-, 2-, 5- and 10-year follow-ups, including the KOOS. Information regarding ACL revision surgery is recorded separately and subsequently combined with data on primary ACLR using the patient’s social security numbers. The registry has been described in more detail in previous literature.19 20
Data collection and study sample
This study included patients who underwent primary ACLR between 2005 and 2020 and were at least 15 years old at the time of surgery, with 1-year follow-up outcome data. Patients who had previously undergone knee surgery, had a concomitant fracture or had a concomitant posterior cruciate ligament or neurovascular injury were excluded. In addition, less commonly used femoral (staple, AO screw, retro screw, metal interference screw with Endopearl backup fixation, Graftmax, XO-button, ‘other’) and tibial fixation types (cobra, staple, Endobutton, Mitek anchor, ‘other’) were excluded. The study sample was divided into three different groups: (1) primary ACLR (patients undergoing only one ipsilateral ACLR surgery), (2) rACLR (patients undergoing only one ipsilateral rACLR surgery) and (3) mrACLR (patients undergoing at least two ipsilateral rACLR surgeries).
Data on patient demographical (age, body mass index (BMI), sex), injury (other concomitant injuries, activity at the time of injury) and surgical characteristics (time from injury to surgery, fixation device, ACL graft type) were additionally obtained from the registry. The activity at the time of injury was divided into six different groups: (1) alpine/skiing; (2) pivoting sport (American football/rugby, basketball, dancing, floorball, gymnastics, handball, ice hockey/bandy, martial arts, racket sports, soccer, volleyball, wrestling); (3) non-pivoting sport (cross-country skiing, cycling, horseback riding, motocross/endure, skateboarding, snowboarding and surfing/wakeboarding); (4) other physical activity (other recreational sport, exercise, trampoline); (5) traffic-related and (6) other (other outdoor activity and work). The tibial fixation devices were categorised into different groups, with six different subcategories for tibial fixation devices: (1) interference screw (metal screw, metal screw with backup staple fixation, resorbable screw, resorbable screw with backup post-fixation, metal screw with backup osteosuture, intrafix); (2) intratunnel fixation (rigidfix); (3) suture post (AO screw, suture washer); (4) retroscrew; (5) fixed suspensory fixation (retrobutton); (6) adjustable suspensory fixation (tightrope), and four different subcategories for femoral fixation devices: (1) fixed suspensory fixation (endobutton, retrobutton, ezloc); (2) intratunnel fixation (rigidfix, transfix); (3) interference screw (metal screw); (4) adjustable suspensory fixation (toggleloc, ultrabutton).
Outcome measures
The primary outcome of interest was the 1-year postoperative PASS for KOOS subscales, thus, the 1- and 2-year KOOS outcomes were considered the same follow-up data.21 Each subscale is scored from 0 to 100, with a higher score indicating better outcomes.22 The responses are rated on a 5-point Likert Scale ranging from 0 to 4. While the KOOS was initially designed for knee osteoarthritis, it has also been used in other orthopaedic knee injuries/conditions, including ACLR, to assess outcomes following a surgical treatment.10 22 Additionally, the predictors for KOOS Sport/Rec and QoL subscales were evaluated in patients undergoing mrACLR. The KOOS questionnaire comprises five subscales, namely Pain, Symptoms, Sport/Rec, QoL and Activities of Daily Living (ADL). To exceed the PASS cut-offs was defined as achieving a PASS indicating that the patient is satisfied with their current symptom state. The PASS cut-offs (sensitivity; specificity) for patients undergoing ACLR have been previously reported to be: 88.9 (0.82; 0.81) for the KOOS Pain, 57.1 (0.78; 0.67) for the KOOS Symptoms, 100.0 (0.70; 0.89) for the KOOS ADL, 75.0 (0.87; 0.88) for the KOOS Sport/Rec and 62.5 (0.82; 0.85) for the KOOS QoL.8 The PASS cut-offs were determined by asking the study subjects to answer the question, ‘Taking into account all the activity you have during your daily life, your level of pain, and also your activity limitations and participation restrictions, do you consider the current state of your knee satisfactory?’.8
Statistical analyses
All statistical analyses were performed by using SAS System for Windows software (V.9.4, SAS Institute, Cary, North Carolina, USA). Count (n) and proportion (%) were used to present categorical variables, while mean with SD and median with range were used for presenting continuous and ordinal data, respectively. For comparisons between groups χ2 test was used for non-ordered categorical variables and the Kruskal-Wallis test was used for continuous variables. For pairwise comparisons between groups, the Fisher’s exact test (two-sided) was used due to dichotomous variables, while χ2 test was used for non-ordered categorical variables. Fisher’s non-parametric permutation test was used for continuous variables. Finally, univariable logistic regression analyses were used for predictor analyses and presented as OR and area under the receiver operating characteristic. The level of significance was set to 0.05.
Results
Baseline characteristics
Out of the 22 928 patients who were included in the study, 21 748 underwent primary ACLR, 1144 underwent rACLR and 36 underwent mrACLR (table 1). The age at the time of the index ACLR was significantly different between the groups, with patients who underwent rACLR and mrACLR being significantly younger than patients who had only undergone primary ACLR (23.0 vs 22.3 vs 29.0; p=0.002). Additionally, patients who underwent mrACLR had significantly shorter mean time from primary ACLR to first revision than those patients undergoing rACLR (2.34 years vs 3.27 years; p=0.032). Finally, a greater proportion of patients undergoing rACLR had lateral meniscus injuries at the time of the index ACLR compared with those who underwent primary ACLR (27.4% vs 23.9%; p=0.0043). Baseline characteristics prior to the latest ACLR surgery can be found in online supplemental table S1.
Supplemental material
Baseline characteristics prior to the index ACLR
Postoperative outcomes
A significant difference was found in the percentage of patients achieving PASS across all KOOS subscales in patients who underwent primary ACLR versus patients who underwent rACLR (table 2 and figure 1). For example, 51.4% of patients undergoing primary ACLR surgery achieved PASS for the KOOS QoL subscale, while only 26.9% of patients treated with rACLR achieved PASS for the same subscale 1 year after the latest ACLR. No difference was found in the percentages of patients reaching PASS for all KOOS subscales between patients undergoing rACLR versus mrACLR. Mean values for the KOOS subscales in patients undergoing primary ACLR, rACLR and mrACLR can be found in online supplemental table S2. A significant difference was found in postoperative mean KOOS values in all subscales for primary ACLR compared with rACLR and mrACLR (online supplemental table S2). Finally, there were no significant predictors for achieving the PASS for the KOOS QoL and Sport/Rec subscales in patients undergoing mrACLR (tables 3 and 4).
Percentages of patients meeting PASS for all KOOS subscales by procedure. *p<0.001 when comparing ACLR to rACLR. ACLR, anterior cruciate ligament reconstruction; KOOS, Knee injury and Osteoarthritis Outcome Score; mrACLR, multiple revision anterior cruciate ligament reconstruction; PASS, Patient-Acceptable Symptom State; QoL, Quality of Life; rACLR, revision anterior cruciate ligament reconstruction; Sport/Rec, Function in Sport and Recreation.
Postoperative PASS value for the KOOS subscales
Predictors of KOOS PASS QoL at 1-year follow-up
Predictors of KOOS PASS Sport/Rec at 1-year follow-up
Discussion
The main findings of this study were that patients undergoing ACLR in the revision setting had statistically lower percentages of reaching PASS for the KOOS 1 year postoperatively than patients undergoing primary ACLR. Across all KOOS subscales, the percentages of patients meeting PASS thresholds were statistically lower for rACLR compared with primary ACLR. Furthermore, despite the lack of statistical significance most likely due to the small sample size, percentages of patients meeting PASS for all KOOS subscales 1 year postoperatively were lower for those undergoing mrACLR compared with patients with primary ACLR. Finally, percentages of patients reaching PASS thresholds for all KOOS subscales 1 year postoperatively were comparable between patients undergoing rACLR and mrACLR and no significant predictors for achieving the PASS for the KOOS QoL and Sport/Rec subscales in patients undergoing mrACLR were found.
Percentages of patients meeting PASS for KOOS subscales postoperatively after primary ACLR in this study were comparable to those in the literature.11 15 23 24 A 2018 cohort study reporting on factors associated with reaching PASS for the KOOS subscales 1 year postoperatively after primary ACLR found that, out of 343 patients, 57% met PASS for the KOOS Pain, 85% for the KOOS Symptoms, 40% for the KOOS ADL, 52% for the KOOS Sport/Rec and 50% for the KOOS QoL.15 This study found similar results after primary ACLR for some subscales, as 93% met PASS for the KOOS pain, 31% for the KOOS ADL, 46% for the KOOS Sport/Rec and 51% for the KOOs QoL. However, little data exists reporting on patients meeting postoperative PASS thresholds for the KOOS after rACLR and mrACLR. While this study does report that percentages of patients meeting PASS for the KOOS after ACLR in the revision setting is much lower than in the primary setting, it is important to consider that PASS thresholds used in this study to assess rACLR and mrACLR are still those that have been established for primary ACLR. As decreased knee functional KOOS outcomes may be expected after ACLR in the revision setting compared with the primary setting,4 5 25 future prospective work should consider creating PASS thresholds for the KOOS for the revision setting as more realistic expectations for knee function in this cohort should be established.
Furthermore, younger age has been reported as a known risk factor for failure after primary ACLR.26 27 This aligns with the current study’s findings, as patients undergoing rACLR and mrACLR were significantly younger than those undergoing primary ACLR at the time of the index procedure (23.0 vs 22.3 vs 29.0). Proposed explanations for this finding include patients of younger age having incomplete neuromuscular maturity as well as a higher likelihood to return to strenuous cutting and pivoting sports and to partake in risk-taking behaviours.26 28
Finally, previous work has reported factors associated with reaching PASS for the KOOS subscales after ACL injury. Studies have shown that early, operative intervention in the form of ACLR increased the chances of reaching PASS for the KOOS subscales as compared with non-surgical treatment after ACL rupture.11 23 Younger age, male sex, higher preoperative KOOS scores and participation in preoperative exercise plans have been reported as characteristics increasing odds of reaching KOOS PASS 1 year postoperatively after primary ACLR15 29 while workers’ compensation status and a diagnosis of diabetes have been linked to decreased odds of reaching KOOS PASS in the same postoperative time period.29 Yet, limited research exists attempting to identify predictive factors of reaching PASS for the KOOS subscales in the rACLR setting. This study attempted to predict factors associated with reaching PASS for the KOOS QoL and KOOS Sport/Rec 1 year postoperatively after mrACLR. Yet, no predictive factors were found in the analysis. This finding may be due to the small sample size of patients in the study undergoing mrACLR and subsequently reaching PASS for these KOOS subscales postoperatively. Yet, as the number of rACLRs continues to rise, it is important to understand the predictive factors associated with the most successful functional outcomes after revision surgery.
While this study does provide valuable information on percentages of large sample sizes of patients reaching acceptable symptom states after primary and rACLR, there are several limitations worth discussing. The reliance on registry data introduces potential limitations in establishing definitive cause-and-effect relationships and may result in confounding by indication. Additionally, the original validation of the KOOS instrument was conducted with patients with knee osteoarthritis, which may restrict its construct validity when assessing outcomes following ACLR.30 31 Also, the PASS values used in this study were originally determined for primary ACLR and may not accurately assess patients’ symptom states when applied to cohorts of patients with different characteristics, such as those in the revision setting. This may limit the possibility of finding significant differences between the groups in some of the KOOS subscales. Therefore, future studies could benefit from establishing new, more accurate PASS values for revision cases to evaluate the functional outcomes more comprehensively in patients undergoing rACLRs.
Conclusions
Patients undergoing ACLR in the revision setting had lower rates of reaching acceptable symptom states for functional knee outcomes than those undergoing primary ACLR. However, no significant predictors for achieving the PASS for the KOOS QoL and Sport/Rec subscales in patients undergoing mrACLR were found.
Data availability statement
Data are available upon reasonable request. The datasets obtained analysed during the current study are available from the corresponding author on reasonable request.
Ethics statements
Patient consent for publication
Ethics approval
This study involves human participants and this study was approved by the Regional Ethical Board in Stockholm, Sweden (2011/337-31/3), and the Swedish Ethical Review Authority (2022-00913-01), and was performed in accordance with the Declaration of Helsinki. The Swedish National Knee Ligament Registry complies with the Swedish legislation related to data security and therefore, no informed consent is necessary for national databases in Sweden.
Acknowledgments
The authors would like to thank statistician Bengt Bengtsson from the Statistiska Konsultgruppen for help with the statistical analyses.
References
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Footnotes
X @senorski
Contributors All listed authors have contributed substantially to this work: literature search and primary manuscript preparation were performed by ZJH, JK and AG. EHS, VM and KS assisted with study design, interpretation of the results, as well as editing and finalising the manuscript. KS is responsible for the overall content. All authors have read and approved the final manuscript to be submitted and published.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests EHS is an associate editor of the Journal of Orthopaedic and Sports Physical Therapy (JOSPT). VM reports educational grants, consulting fees, and speaking fees from Smith & Nephew Plc, educational grants from Arthrex and DePuy/Synthes, consulting fees from Newclip, and is a board member of the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS), and deputy editor-in-chief of Knee Surgery, Sports Traumatology, Arthroscopy (KSSTA). KS is a member of the Board of Directors in Getinge AB (publ).
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.